Keyphrases
Active Pharmaceutical Ingredients
51%
Amorphous Form
76%
Amorphous Solid Dispersion
54%
Amorphous Solids
49%
Aqueous Solubility
49%
Bulk Material
43%
Cancer Treatment
43%
COVID-19
43%
COVID-19 Guidelines
43%
Cross-linked Gel
43%
Crystal Engineering
43%
Crystalline Formulation
43%
Crystallization Kinetics
43%
Dissolution Enhancement
43%
Dolutegravir
43%
Drug Delivery
43%
Engineering Approach
43%
Hay Fever
43%
In-process
43%
Influenza
51%
Kinetic Study
43%
Lamivudine
43%
Material Formulation
43%
Morphological Study
43%
Nanoengineering
43%
Neoplastic Disease
43%
Nervous System Diseases
43%
Pharmaceutical Formulations
43%
Pharmaceutical Products
43%
Physical Stability
87%
Polyol
54%
Preparation Method
43%
Quality by Design
43%
Robust Stability
43%
Roxithromycin
43%
Simultaneous Detection
43%
Sinusitis
51%
Solid Dispersion
100%
Solid-state Form
79%
Solubility Enhancement
54%
South Africa
43%
Stability Indicating HPLC
43%
Stability Kinetics
43%
Sulfadoxine
43%
Tenofovir Disoproxil Fumarate
43%
Therapeutic Agents
54%
Thermal Processing
43%
Thermodynamic Study
43%
Xylitol
43%
Zopiclone
43%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
10%
Allergic Rhinitis
20%
Amorphous Solid Dispersion
58%
Angiotensin Receptor Antagonist
14%
Antibiotics
10%
Anticarcinogen
21%
Bioavailability
25%
Carbohydrates
43%
Central Nervous System Disease
43%
Central Nervous System Drug
43%
Combination Therapy
12%
Communicable Disease
14%
Controlled Drug Release
43%
Coronavirinae
43%
Crystal Engineering
43%
Crystallization Kinetics
43%
Differential Scanning Calorimetry
28%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Disease
69%
Dolutegravir
43%
Dosage Forms
61%
Drug Delivery System
43%
Drug Solubility
14%
Drug Stability
43%
Excipient
43%
Glucose
10%
High Performance Liquid Chromatography
43%
Incubation Time
14%
Influenza
16%
Isoniazid
36%
Lamivudine
43%
Malignant Neoplasm
43%
Maltitol
43%
Mannitol Plus Sorbitol
10%
Methanol
14%
Neoplasm
43%
Non-Steroidal Anti-Inflammatory Drug
14%
Pollen Allergy
43%
Polyol
58%
Povidone
13%
Reverse Phase High Performance Liquid Chromatography
43%
Roxithromycin
43%
Scanning Electron Microscopy
35%
Sinusitis
58%
Stability of Solid
14%
Sulfadoxine
43%
Tenofovir Disoproxil
43%
Vaccine Development
14%
Xylitol
43%
Zopiclone
43%